Associated Papers
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.
Ren X et al.
Journal of Cancer Research and Clinical Oncology, 2024
38466449 (PubMed )
Supplement: 432_2024_5626_MOESM11_ESM.xls › Sheet1
A microscopic landscape of the invasive breast cancer genome.
Ping Z et al.
Scientific Reports, 2016
27283966 (PubMed )
Supplement: srep27545-s1.xls › suppl_table_1_IDC_histologic_gr
Comprehensive molecular portraits of human breast tumours.
Unknown Author
Nature, 2012
23000897 (PubMed )
Supplement: NIHMS393293-supplement-2.xls › SuppTable1
Select a paper to view details